使い捨てシリンジの世界市場-2022-2029

市場力学

世界の使い捨てシリンジ市場の成長は、使い捨てシリンジの認知度を高める様々なNGOの活動の増加、HIVなどの疾病の蔓延を抑制する必要性、注射薬の需要増加など、特定の要因に牽引されています。

交通事故の増加により、予測期間中に世界の使い捨てシリンジ市場を牽引すると予想されます。

主に、従来のドラッグデリバリー方法ではバイオアベイラビリティが不十分であることから、注射薬の使用が著しく増加しています。経口投与される薬物の多くは、初回代謝時に分解されるため、全身循環に到達するまでに効果がなくなってしまいます。一方、注射剤は直接全身に行き渡るため、より早く効果を発揮することができます。さらに、針刺し事故が増加していることも、安全注射器の需要を高めています。このような利点も、注射器の採用が増え、その結果、世界の使い捨てシリンジ市場が成長する要因となっています。さらに、ワクチン需要の増加により、世界の発展途上地域でも注射器、特に使い捨てシリンジの売上が増加すると予想されます。

主に生物製剤を含む注射剤部門の持続的な成長は、世界の使い捨てシリンジ市場を牽引する主要因となっています。臨床開発中の医薬品の60％以上が生物製剤です。このことは、生物製剤市場の力強い成長を示しています。そして、これが使い捨てシリンジ市場を押し上げると予想されます。ポイントオブケア投与の需要の高まりと使い捨てシリンジの製造における技術的進歩は、世界の使い捨てシリンジ市場に燃料を供給しています。

2段階使い捨て自動注射器の導入などの画期的な技術革新は、世界の使い捨てシリンジ市場の成長を後押ししています。使い捨てシリンジ市場の企業は、様々な薬物の粘性に対応する装置を導入するための努力を増やしています。また、システム部品をカスタマイズする必要性をなくすために、機器の設計改良に重点を置くようになってきています。新しい2段階使い捨て自動注射器は、不完全に統合されたシステムに関連する破損や非互換性の課題を克服しています。

使い捨てシリンジに関連する厳しい規制が使い捨てシリンジ市場の成長を阻む

使い捨てシリンジは、アレルギー反応、創傷剥離、皮膚感染など、その使用性と安全性に関連したいくつかの制約があります。また、FDAではクラスII、インドではDrugs and Cosmetics Acts（1940）でクラスBに分類され、少しリスクが高いため、臨床試験が必要となり、さらに法的複雑性につながっています。これらの材料の安全性、品質、性能は、公衆衛生のために厳しい評価を必要とする側面があり、そのために複雑で厳しい所属の規制を受けることになります。したがって、これらの要因は使い捨てシリンジ市場の成長を妨げています。

産業分析

世界の使い捨てシリンジ市場は、ポーターのファイブフォース分析、サプライチェーン分析、規制分析、価格分析、製品分析などの様々な産業要因に基づいて、市場の詳細な分析を提供します。

世界の使い捨てシリンジ市場レポートでは、約40以上の市場データ表、45以上の図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

• 製品別市場内訳
• アプリケーション別市場内訳
• エンドユーザー別市場内訳
• 地域別市場内訳

第4章 ダイナミクス

• 市場影響要因
• 促進要因
  • 使い捨てシリンジの使用に関する意識を高める様々なNGOの活動の増加
  • HIVのような疾病の蔓延を抑制する必要性
  • 注射薬の需要増加
• 抑制要因
  • 比較的高い一回限りのコスト
• 厳しい政府規制
• ビジネスチャンス

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析
• 価格設定分析
• 製品分析
• ポストセールスサービス分析

第6章 製品別

• 従来型使い捨てシリンジ
• 安全使い捨てシリンジ
• ニードル
• 経口シリンジ
• 充填用ニードル

第7章 アプリケーション別

• 予防接種用注射器
• 治療用注射

第8章 エンドユーザー別

• 病院
• 診断研究所
• 血液銀行
• 製薬業界
• ワクチン接種
• 動物用医薬品

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第10章 競合情勢

• 競合シナリオ
• 市況ポジショニング／シェア分析
• M&A（合併・買収）分析

第11章 企業プロファイル

• Baxter International Inc.
  • 企業概要
  • 製品ポートフォリオと説明
  • 主な発展状況
  • 財務概要
• B. Braun Melsungen AG
• Becton
• Dickinson and Company
• Cardinal Health
• Henke-Sass Wolf
• Nipro Medical Corporation
• Novo Nordisk A/S
• Retractable Technologies, Inc.
• Vita Needle Company（*List is not exhaustive）

第12章 DataM

Market Overview

Disposable Syringes Market is estimated to reach at a CAGR of 6.5% during the forecast period (2022-2029).

Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop bodily fluids flow.

Advancements in the Disposable Syringes market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to surgical glue's favorable biological and physical properties, more surgeons are using this technique to seal wounds. Disposable Syringes is derived from several natural biopolymers, including gelatin, collagen, chitosan, albumin, and fibrin. A syringe designed for one-time use and is discarded after the use is called a disposable syringe. Furthermore, a syringe is defined as a sterile cylindrical medical instrument that has a thin hollow needle at the end. Besides, this device acts as a pump, which is used to draw therapeutic liquid formulations from vials and deliver them to a patient's bloodstream. However, within more modern times, the disposable syringe has risen in popularity over the traditional reusable syringe. The primary difference being that a disposable syringe is intended for one-time use and is then disposed of, typically into a contamination unit.

Market Dynamics

The global disposable syringes market growth driven by certain factors such by increasing number of activities by various NGOs that create awareness for disposable syringes, the need to control the spread of diseases like HIV, and the rising demand for injectable drugs.

Increasing incidences of road accidents, is expected to drive the global disposable syringes market during the forecast period

There has been a marked increase in the use of injectable drugs, primarily due to the lack of bioavailability in conventional drug delivery methods. Many orally administered drugs are subject to decomposition during the first-pass metabolism, which renders them ineffective by the time they reach the systemic circulation. On the other hand, injectable drugs directly enter the systemic circulation and provide the desired effect with a quicker onset of action. Furthermore, there are rising cases of needlestick injuries that are driving the demand for safety syringes. These advantages are also responsible for the increased adoption of injectable drugs and the global disposable syringes market's consequent growth. Furthermore, the increasing demand for vaccines is expected to drive syringes' sales, particularly disposable syringes, in the developing regions of the world.

The sustained growth of the injectable drugs sector, which primarily includes biologics, is the major factor driving the global disposable syringes market. More than 60% of drugs in clinical development are biologics. This indicates the strong growth of the biologics market. In turn, this is expected to boost the disposable syringes market. The rise in demand for point-of-care administration and technological advancements in the manufacturing of disposable syringes fuel the global disposable syringes market.

Ground breaking innovations such as introducing two-step disposable auto-injector devices are bolstering the growth of the global disposable syringes market. Companies in the market for disposable syringes are increasing efforts to introduce devices that cater to different drugs' viscosities. They are increasing focus to deliver design improvements in devices that eliminate the need for customizing system components. Novel two-step disposable autoinjector devices are overcoming challenges of breakage and incompatibility associated with poorly integrated systems.

Strict regulations associated with Disposable Syringes hampering the growth of the Disposable Syringes market

Disposable Syringes has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. Besides, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the Disposable Syringes market.

Industry Analysis

The global Disposable Syringes market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, product analysis etc.

Segment Analysis

The cyanoacrylates segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many types of glue. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue, the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low heat level is generated when this polymerization starts. Consequently, the patient does not experience the stinging or burning sensation that occurs with some competitor products.

Cyanoacrylate glue is biocompatible and does not need removal as it naturally slough off the skin as part of the natural wound healing process. Cyanoacrylate properties, namely fast-setting, high tensile strength polymers that bind with the skin's surface and are flexible, durable, waterproof, and transparent on the setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and enhance the patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible, and require no dressing on the wound.

Geographical Analysis

North America region holds the largest market share of the global Disposable Syringes market

North America region is dominating the global Disposable Syringes market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure and experienced professionals in this region which leads to higher adoption of Disposable Syringes in hospitals, specialty clinics, and diagnostic centers. Also, growing awareness of the benefits of non-invasive medical aesthetic treatments is also boosting the growth of the market. The number of breast augmentation and liposuction procedures in the United States has always been high.

Canada's aesthetic device market is a highly diversified and export-oriented industry that manufactures equipment and supplies where purchasers include Canadian and international hospitals, physician's offices, laboratories, clinics, as well as patients (through direct purchases). The aesthetic device sector is populated with companies driven by product innovation. The industry is able to draw on world-class innovative research being conducted in Canadian universities, research institutes, and hospitals, some of which have been spun-off into Canadian medical device companies. Around 10% of Canada's medical device companies have spun off from Canadian research organizations.

Competitive Landscape

The global Disposable Syringes market is fragmented with the presence of a large number of market players. Some of the major players contributing to the growth of the Disposable Syringes market are Allergan Plc., Bausch Health Companies Inc., Cutera Palomar Medical Technologies, Cynosure Inc., Fosun International Ltd., Fotona Inc., Lutronic Inc., Sciton Inc., among others. Rising awareness toward aesthetic-based skin and body rejuvenation lasers and energy devices have increased the revenue opportunities for leading manufacturers to invest in the Disposable Syringes market.

The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Disposable Syringes market globally. For instance,

• In August 2020, the US-based Sensus Healthcare has acquired mobile aesthetic laser companies Aesthetic Mobile Laser Services and Aesthetic Laser Partners in Florida, US. The transactions are expected to bring in approximately $1m in revenues over the next 12 months.
• In May 2020, AbbVie has completed the acquisition of Allergan. AbbVie planning to launch Allergan Aesthetics, a global subsidiary under the umbrella of the AbbVie-Allergan merger.
• In November 2019, Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT, and gynecology from XIO. The transaction values Lumenis at an enterprise value of over $1 billion.

Key Companies to Watch

Allergan Plc

Overview: Allergan Plc is a bold, global pharmaceutical company. It is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Product Portfolio: CoolTone Device- The CoolTone device is FDA-cleared for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also FDA-cleared for strengthening, toning, and firming of buttocks and thighs.

The global Disposable Syringes market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by End-User
• 3.4. Market Snippet by Region

4. Dynamics

• 4.1. Market Impacting Factors
• 4.2. Drivers
  • 4.2.1. Increasing Activities by Various NGO's that Create Awareness for the Use of Disposable Syringes
  • 4.2.2. Need to Control the Spread of Diseases like HIV
  • 4.2.3. Rising Demand for Injectable Drugs
• 4.3. Restraints
  • 4.3.1. Comparatively High One-time Cost
• 4.4. Stringent Government Regulations
• 4.5. Opportunity

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Pricing Analysis
• 5.5. Product Analysis
• 5.6. Post Sales Services Analysis

6. By Product

• 6.1. Introduction
  • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Conventional Disposable Syringes *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 6.3. Safety Disposable Syringes
• 6.4. Needles
• 6.5. Oral Syringes
• 6.6. Filling Needles

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Immunization injections
• 7.3. Introduction
• 7.4. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 7.5. Therapeutic injections

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals
• 8.3. Introduction
• 8.4. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 8.5. Diagnostic Laboratories
• 8.6. Blood Banks
• 8.7. Pharmaceutical Industry
• 8.8. Vaccination
• 8.9. Veterinary Purposes

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.7.1. The U.S.
    • 9.2.7.2. Canada
    • 9.2.7.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. The U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia Pacific
• 9.6. The Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Baxter International Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Developments
  • 11.1.4. Financial Overview
• 11.2. B. Braun Melsungen AG
• 11.3. Becton
• 11.4. Dickinson and Company
• 11.5. Cardinal Health
• 11.6. Henke-Sass Wolf
• 11.7. Nipro Medical Corporation
• 11.8. Novo Nordisk A/S
• 11.9. Retractable Technologies, Inc.
• 11.10. Vita Needle Company (*List is not exhaustive)

12. DataM Intelligence

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us